HepaRG® Training

Training is co-organized by Biopredic International and Edelweiss Connect 

Our October training will take place on October 29th, 2019 at the Technology Park Basel. We ask you to fill out this registration form to participate.

This first training is offered without cost to a limited number of participants as a special offer. Please contact us for your suggestions and requests on training needs for future training activities. In addition to public classes, customised private training for small groups can be arranged. Submit a training request. 


Hepa-RG® Training Session 

Program Overview 

  • 9.30 - 9.45 Introduction (Tatyana Doktorova, PhD, ERT, Edelweiss Connect) 
  • 9.45 - 10.45 HepaRG®: an integrated model for studying bile canalicular dynamics to understand Cholestatic Toxicity (Ashwani Sharma, PhD, Biopredic International)
    • 10.45 - 11.00 Coffee Break
  • 11.00 - 12.00 The use of HepaRG® cells in genotoxicity screening (Tatyana Doktorova, PhD, ERT, Edelweiss Connect)
  • 12.00 - 12.30 SOPs presentation for use of HepaRG® cells (Loise Valentin, Biopredic International)
    • 12.30 - 13.30 Lunch Break 
  • 13.30 - 17.00 Practical session (Loise Valentin, Ashwani Sharma, Tatyana Doktorova)

HepaRG® cells in both 2D and 3D cultures are promising and relevant in vitro models for prediction of hepatotoxicity. Differentiated HepaRG® cells are highly polarized with substantial levels of uptake and efflux drug transporters, at the same level as the Primary Human Hepatocyte (PHH), and form functional bile canaliculi. Cholestatic drugs can be identified in HepaRG® cells by measuring their effects on bile acid efflux (via direct inhibition of the pumps) or by interfering with the bile canaliculi dilation or contraction. Therefore, during our hands-on training, we will demonstrate HepaRG® cell culture process and drug-induced cholestatic liver injury by measuring bile canalicular dynamics. The training will cover the following sections: HepaRG® cell thawing, counting and seeding for 2D and 3D cell cultures Microscopic observation of HepaRG® cells at different stages of differentiation Functional assay: drug-induced cholestasis evaluation

Latest Tweets

Edelweiss Connect (6 days ago)
RT @EU_ToxRisk: The EU-ToxRisk NAM-based Testing Commercialization Platform presented during the @EU_ToxRisk Open Symposium, Feb 12, 2020 i…
Edelweiss Connect (1 week ago)
RT @Biopredic_Intl: We are glad to announce the launch of the new HepaRG #logo !! Worldwide recognized and quite unique human hepatic stem…
Edelweiss Connect (2 weeks ago)
The SafeDESIgn imaging-based toxicity reporter platform for chemical safety assessment #SaferWorldbyDesign… https://t.co/7xeN1d6w6t
Edelweiss Connect (4 weeks ago)
The latest #OpenTox webinar focused on #AOPs current trends and developments, presented by Tatyana Doktorova https://t.co/ZKj5PivfiN
Edelweiss Connect (4 weeks ago)
RT @barryhardy: Tatyana Doktorova will discuss current trends and developments in Adverse Outcome Pathways as exemplified by case studies (…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA